It has now been one month since the US Department of Health and Human Services (HHS) Office of the National Coordinator for Health Information Technology (ONC) sent its proposed information blocking rule to the Office of Management and Budget (OMB)
Health & Life Sciences News
Exploring Critical Business and Legal Issues across the Health Care and Life Sciences Industries
Health & Life Sciences News, published by McDermott Will & Emery, focuses on legal and regulatory developments affecting the healthcare and life sciences sectors. The blog covers topics such as healthcare mergers and acquisitions, compliance programs, antitrust considerations, provider collaborations, and the impact of public health emergencies like COVID-19 on healthcare operations and life sciences companies. It also addresses FDA regulatory issues, clinical trial innovations, supply chain challenges, and government assistance programs relevant to healthcare and life sciences businesses. The content includes analysis of transactional, compliance, and policy matters shaping the industry landscape.
Latest from Health & Life Sciences News - Page 6
Key Considerations for a Seamless Practice Acquisition
For physician practice management (PPM) organizations going through an acquisition processes – whether by a physician group or a private equity firm – one idea should remain top-of-mind: integration must start before the closing.
The Harvard Business Review states that…
PART 2 – Regulating Nonprofit Health Care: Insights from State Attorneys General
McDermott recently launched the second episode of its special edition podcast providing an in-depth discussion of the interplay between State Attorneys General enforcement authority and nonprofit Board of Directors responsibility in the governance and operation of health systems. This special…
The Importance of Ongoing Physician Collaboration, Engagement and Integration in PPM Management
In partnerships, the key to success lies in communication, understanding, and involvement. This certainly applies to PPMs, which learned in the 1990s that an “us versus them” mentality between physicians and the management companies can lead to economic turmoil.
To…
Regulating Nonprofit Health Care: Insights from State Attorneys General
FTC to Look Closely at Competition between Biologics and Biosimilars and Patent Protection Strategies of Branded Manufacturers
WHAT HAPPENED
On July 18, 2018, US Food and Drug Administration (FDA) Commissioner Scott Gottlieb delivered a speech at The Brookings Institution in Washington, DC, discussing how to bolster competition from biosimilars while maintaining innovation.
The Commissioner noted the absence…
Three Environmental Factors Impacting the PPM Industry and Getting Deals Done
The PPM industry is by no means immune to the ebbs and flows of a traditional marketplace. Since the consolidation bubble burst in the 1990s, PPMs have gone from practically extinct to a once-again substantial component of the health care…
Medicare Hearings and Appeals: Litigation, New Initiatives, and Opportunities to Exit the Backlog
Providers continue to face a massive Medicare appeals backlog before the Office of Medicare Hearing and Appeals (OMHA). Pending appeals number in the hundreds of thousands and the current average processing time for an appeal is over three years, with…
We’ll see you at BIO 2018
McDermott is gearing up for an exciting week of programming during the 2018 BIO International Convention. A number of McDermott partners will on the ground as panelists and moderators across a range of programs during BIO and we hope to…
Looking Back at PPM/ASC 2018: What We Learned in Nashville
The health care field is evolving at light speed, adapting to changing patient, physician and payer expectations. This is particularly evident in the physician practice management (PPM) and ambulatory surgery center (ASC) industries. We gathered recently in Nashville, Tennessee for…